NADMED is one of ten companies chosen for the Deep Tech Accelerator Funding program. The companies selected in the program aim at high social impact and seek to solve major global problems and have been founded to commercialize the latest research results and...
NADMED attends the premier international conference on mitochondrial disease EUROMIT 11-15 June. The prestigious five-day event will host talks from globally renowned experts in the mitochondrial field, an exceptional opportunity to share information about the study...
A recent study with mice suggests NAD+ repletion with niacin counteracts cancer cachexia. The study published in Nature Communications implies that NAD+ repletion, using vitamin B3 niacin, efficiently corrects tissue NAD+ levels. Therapy that was used in cachectic...
Doctors in the U.S. can now access a novel NAD blood diagnostic for their patients. TruDiagnostic kit allows blood collection at doctors’ offices or at home. After posting the samples to the TruDiagnostics laboratory they are analyzed with NADMED technology....
A recently published study in Science Advances shows benefits of long-term NR supplementation, but also its potential undesired effects highlighting the benefits of measuring NADs. While the researchers found out that NR improved systemic NAD+ metabolism and muscle...
NADMED technology was used in a clinical case study about an adult patient diagnosed with NADSYN1 associated congenital NAD deficiency. Research conducted at Danish university hospitals showed a deficiency in the patient’s NAD pool compared to his healthy...
